Ph II Study of Perifosine Plus Gleevec for Patients With GIST

NCT00455559 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: Perifosine
DRUG: Imatinib Mesylate

Sponsor

AEterna Zentaris

Collaborators

[object Object]